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Abstract
Background: Leptospirosis has a varied clinical presentation with complications like myocarditis and acute renal
failure. There are many predictors of severity and mortality including clinical and laboratory parameters. Early
detection and treatment can reduce complications. Therefore recognizing the early predictors of the complications
of leptospirosis is important in patient management. This study was aimed at determining the clinical and
laboratory predictors of myocarditis or acute renal failure.
Methods: This was a prospective descriptive study carried out in the Teaching Hospital, Kandy, from 1st July 2007
to 31st July 2008. Patients with clinical features compatible with leptospirosis case definition were confirmed using
the Microscopic Agglutination Test (MAT). Clinical features and laboratory measures done on admission were
recorded. Patients were observed for the development of acute renal failure or myocarditis. Chi-square statistics,
Fisher’s exact test and Mann-Whitney U test were used to compare patients with and without complications. A
logistic regression model was used to select final predictor variables.
Results: Sixty two confirmed leptospirosis patients were included in the study. Seven patients (11.3%) developed
acute renal failure and five (8.1%) developed myocarditis while three (4.8%) had both acute renal failure and
myocarditis. Conjunctival suffusion - 40 (64.5%), muscle tenderness - 28 (45.1%), oliguria - 20 (32.2%), jaundice - 12
(19.3%), hepatomegaly - 10 (16.1%), arrhythmias (irregular radial pulse) - 8 (12.9%), chest pain - 6 (9.7%), bleeding -
5 (8.1%), and shortness of breath (SOB) 4 (6.4%) were the common clinical features present among the patients.
Out of these, only oliguria {odds ratio (OR) = 4.14 and 95% confidence interval (CI) 1.003-17.261}, jaundice (OR =
5.13 and 95% CI 1.149-28.003), and arrhythmias (OR = 5.774 and 95% CI 1.001-34.692), were predictors of
myocarditis or acute renal failure and none of the laboratory measures could predict the two complications.
Conclusions: This study shows that out of clinical and laboratory variables, only oliguria, jaundice and arrhythmia
are strong predictors of development of acute renal failure or myocarditis in patients with leptospirosis presented
to Teaching Hospital of Kandy, Sri Lanka.
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Background
Leptospirosis is endemic in both urban and rural areas
of Sri Lanka and there had been many outbreaks in the
recent past [1]. In year 2007, 2187 suspected cases were
reported in Sri Lanka while 147 cases were reported
from the Kandy District [2]. In the most recent
epidemic of leptospirosis in 2008, the number of cases
have increased to 7099 and the number of deaths has
gone up to 204 (6 fold increase compared to 2007) [3].
Clinical leptospirosis can vary from a mild non-speci-
fic influenza-like infection to a severe disease, where ser-
ious complications like acute renal failure, myocarditis,
pulmonary haemorrhage and liver failure are reported
[4]. Case fatality rates are varied significantly between
3% and 54% based on the affected organ-system [5,6].
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dreaded complications of leptospirosis. Rajiv et al. has
shown that 70% of the patients with serologically proven
leptospirosis had electrocardiographic abnormalities,
with atrial fibrillation being the commonest major
arrhythmia noted [7]. The same study showed that 36%
of the patients had conduction system abnormalities and
30% had T wave changes. Another case series has
reported atrio - ventricular block in 44% of patients
with leptospirosis [8]. A glycoprotein fraction of leptos-
piral cell wall has been incriminated in the pathogenesis
of these rhythm disturbances. Other reported cardiac
abnormalities include myocarditis and endocarditis [9].
Renal involvement is the most serious complication in
leptospirosis and is the commonest cause of death [10].
Two mechanisms have been postulated in the produc-
tion of leptospiral renal failure: (1) direct nephrotoxicity
brought about by various endotoxins or endotoxin-like
substances and (2) anoxic effect due to disturbances in
renal circulation. The typical lesion is tubulointerstitial
nephritis, characterized by interstitial edema and dense
focal infiltration of predominantly mononuclear cells.
Tubular changes are degenerative in nature and affect
principally the proximal tubules. Intravascular volume
depletion causing the vasomotor nephropathy in this
disease has been postulated to occur from capillary leak-
age with associated loss of fluid and protein, hence the
proteinuria [10].
Severe leptospirosis may carry a high mortality if
treatment is not instituted early. Poor prognostic mar-
kers in leptospirosis reported in various studies include
hypotension, oliguria and hyperkalemia [11]. Other stu-
dies have reported dyspnea, white blood cell count
greater than 12,900/mm
3 [12], repolarization abnormal-
ities on electrocardiograms, alveolar infiltrates [13],
hemoptysis, metabolic acidosis, and thrombocytopenia.
In hospitals that have adequate facilities, patients with
these risk factors should preferably be treated in an
intensive care unit [14].
The beginning of early pertinent antimicrobial therapy
within 4-5 days after the onset of illness, proper suppor-
tive therapy and use of dialysis to treat renal failure has
reduced the leptospirosis-related mortality [15]. There-
fore early predictors of complications are helpful in
detecting and managing patients with leptospirosis and
also to minimize the mortality. The present study was
aimed at determining which clinical and laboratory find-
ings can predict the development of myocarditis or
acute renal failure.
Methods
Study setting
This study was carried out in the medical wards of
Teaching Hospital Kandy, Sri Lanka, which is a tertiary
care hospital. This medical unit treats about 10,000
patients per year and 10% of the admissions are due to
fever, out of which substantial proportion is due to lep-
tospirosis. Ethical approval was granted by the Ethical
Committee of the Teaching Hospital {No: AB (II)/ETHI-
CAL/2007}. Study population included patients with lep-
tospirosis who were admitted to wards 33 and 35, from
1st July 2007 to 31st July 2008. Patients without a sero-
logical proof or who died before serologically proving
leptospirosis were excluded.
Procedure
Patients with clinical features of leptospirosis were
screened using a symptom check list and interviewer
administered questionnaire to diagnose leptospirosis
according to the leptospirosis case definition. Surveil-
lance case definition for diagnosis of leptospirosis which
was published by the Epidemiology Unit was used for
the present study [16]. Nine clinical features which were
thought to predict complications were recorded. The
clinical features were chest pain, shortness of breath
(SOB), oliguria, jaundice, bleeding, conjunctival suffu-
sion, arrhythmias (irregular radial pulse), muscle tender-
ness, and hepatomegaly. Blood samples were taken on
admission for Hemoglobin (Hb), packed cell volume
(PCV), white blood cell count (WBC), bilirubin, platelet
count (PLC), blood urea (BU), serum potassium (K), and
creatinine.
Leptospirosis was confirmed using the genus specific
Microscopic Agglutination Test (MAT) done on blood
samples drawn on 7th day of fever. Informed written
consent was obtained from patients before participating
in the study as well as before blood sampling. The MAT
was done in Medical Research Institute (MRI) Colombo
which uses the non pathogenic Patoc strain of Leptos-
pira biflexa. A positive MAT test was defined as a titre
of ≥1: 800 in acute phase serum. This is the titre speci-
fied by the MRI which is the national reference labora-
tory [17].
Only the laboratory confirmed patients were included
in the study. The patients were observed for the devel-
opment of acute renal failure or myocarditis alone or in
combination.
Acute renal failure was defined as the presence of one
of the following criteria
￿ An increase in serum creatinine of > 0.5 mg/dl.
￿ An increase in serum creatinine of > 50% from
baseline.
￿ A reduction in calculated creatinine clearance of >
50%.
￿ Need for dialysis.
Myocarditis was defined as reduction in systolic blood
pressure below 100 mm Hg with one of the following
criteria.
Dassanayake et al. BMC Infectious Diseases 2012, 12:4
http://www.biomedcentral.com/1471-2334/12/4
Page 2 of 6￿ Presence of transient ST segment changes, T wave
changes, or conduction abnormalities in the absence of
electrolyte imbalances.
￿ Reduction of ejection fraction < 40% with character-
istic echocardiographic evidence of myocarditis.
￿ Need for inotropic support.
Statistical analysis
Descriptive analyses of patients with and without com-
plications were done using proportions and percen-
tages. Chi-square statistics, Fisher’s exact test and
Mann-Whitney U test were used to compare patients
with and without complications. All variables with a
“p“ value less than 0.1 were selected for the predictor
model. A logistic regression model was used to evalu-
ate the predictor variables. A backward stepwise elimi-
nation of variables was carried out to select final
variables included in the model. Results were analyzed
using SPSS software.
Results
Sixty two confirmed leptospirosis patients were
included in the study. Mean age of the confirmed
cases of leptospirosis was 39 years with a standard
deviation of 19. The male to female ratio was 3:1.
Seven patients (11.3%) developed acute renal failure
and five (8.1%) developed myocarditis while three
(4.8%) had acute renal failure and myocarditis together.
Table 1 shows the distribution of confirmed cases of
leptospirosis by clinical features and complications
(acute renal failure or myocarditis).
Of the 8 patients who had arrhythmias, 5 (62.5%)
developed complications and among 54 patients without
arrhythmias only 10 (18.5%) developed complications.
This observed difference was statistically significant.
Table 2 shows the distribution of confirmed cases of
leptospirosis by laboratory measures and complications
(acute renal failure or myocarditis).
I nt h eu n i v a r i a t ea n a l y s i s ,patients with complica-
tions had lower Hb, PCV, and platelet count with
higher WBC counts, blood urea, and creatinine levels
compared to those without complications. We used
Mann-Whitney U test due to non-normal distribution
of data.
Those clinical features and laboratory measures were
then entered into a logistic regression model to assess
the predictor values of each variable.
Table 3 shows the results of logistic regression model.
In the backward stepwise elimination process only
three variables were retained in the model. Oliguria,
jaundice and arrhythmias on admission were shown as
predictors of acute renal failure or myocarditis.
Table 1 Distribution of confirmed cases of leptospirosis by clinical features and complications (acute renal failure or
myocarditis)
Clinical feature Complications (acute renal failure or myocarditis) Significance
No Yes
n%n%
Oliguria No 35 83.3 7 16.7 Fisher’s
Yes 12 60.0 8 40.0 p .060
Jaundice No 41 82.0 9 18.0 Fisher’s
Yes 6 50.0 6 50.0 p .054
Bleeding No 43 75.4 14 24.6 Fisher’s
Yes 4 80.0 1 20.0 p .672
Conjunctival suffusion No 18 81.8 4 18.2 Fisher’s
Yes 29 72.5 11 27.5 p 1.000
Arrhythmias No 44 81.5 10 18.5 Fisher’s
Yes 3 37.5 5 62.5 p .016*
Chest pain No 42 75.0 14 25.0 Fisher’s
Yes 5 83.3 1 16.7 p .549
SOB No 44 75.9 14 24.1 Fisher’s
Yes 3 75.0 1 25.0 p .680
Muscle tenderness No 26 76.5 8 23.5 Chi-square
Yes 21 75.0 7 25.0 p .893
Hepatomegaly No 41 78.8 11 21.2 Fisher’s
Yes 6 60.0 4 40.0 p .189
*Significant
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Clinical presentation of leptospirosis can be varied and
non specific, hence the recognition of red flags of com-
plications is of paramount importance. The aim of our
study was to determine such red flags and to formulate
a risk predictor model. Of the many clinical and labora-
tory predictors of mortality which have been described,
we assessed nine clinical and eight laboratory variables
in our study. Furthermore many studies have been con-
ducted to determine the predictors of mortality, but stu-
dies conducted to determine the predictors of
complications were not found in Sri Lankan literature
[18].
Out of the 17 variables assessed, only oliguria, jaun-
dice and arrhythmias were predictors of leptospirosis
complications. Although previous studies have shown
that 70% of leptospirosis patients were having arrhyth-
mias, in our study it was only 12.9%. In another study
acute renal failure was found in 40% of patients which is
a higher value compared to ours. In the same study it
was shown that oliguria is a sensitive sign of severe lep-
tospirosis. This finding is somewhat similar to the find-
ing of ours. Why the clinical severity of leptospirosis
varies so much is so far unexplained but difference in
serovars could be a good reason. Although univariate
analysis showed a significant difference for most of the
laboratory variables, none of them were significant as
predictors in multivariate analysis. Similarly, oliguria and
jaundice showed a significant difference as predictors in
multivariate analysis despite having no significant differ-
ence in univariate analysis. This finding could be due to
the confounding effects of the variables. All three vari-
ables included in the predictor model were strong pre-
dictors and are included in surveillance case definition
of leptospirosis in Sri Lanka as well as other countries.
Although jaundice was found to be a predictor of
complications in our study, a study done in Turkey [19]
has shown that majority of their patients had anicteric
leptospirosis which could also lead to severe disease.
Many previous studies have shown leucocytosis, throm-
bocytopenia and blood urea as early predictors [20].
Interestingly, none of the laboratory measures were
shown to have any value as early predictors of renal or
cardiac complications in our study. This is a valuable
finding as most patients present to rural or district hos-
pitals which lack laboratory facilities, therefore predict-
ing their complications and need for transfer could be
decided using the three clinical criteria alone.
Although many previous studies have shown pulmon-
ary involvement with haemoptysis as a major complica-
tion [14], it was not found in our study. Possible reason
for this could be a different pathogenic serovar circulat-
ing in the area, but this could not be confirmed as we
didn’t analyze for serotypes.
Thrombocytopenia was a common finding in our
patients. Despite this bleeding was uncommon and
unlike in other studies it did not predict the develop-
ment of myocarditis or acute renal failure. Similarly
leucocytosis was also a common finding and it is a
valuable investigation in differentiating leptospirosis
from dengue fever which is deadlier than leptospirosis.
It was also not proven to be effective as a predictor of
complications.
Table 2 Distribution of confirmed cases of leptospirosis by laboratory measure and complications (acute renal failure
or myocarditis)
Laboratory measure Complications (acute renal failure or myocarditis) Significance
1
No Yes
Median IQR Median IQR p
Hb (g/L) 12 12-13 11 11-12 .017*
PCV (%) 38 36-42 36 28-37 .041*
WBC (10
9) 8 6-10 11 10-17 .001*
Bilirubin (mic mol/L) 50 14-80 159 50-400 .086
PLC (10
9) 175 115-220 74 60-190 .037*
BU (mmol/L) 5 4-10 14 5-26 .017*
K (mmol/L) 4 4-5 4 4-5 .755
Creatinine (mg/dl) 0.80 0.60-1.20 2.80 .00-4.00 .0001*
IQR- Inter quartile range,
1 Based on Mann-Whitney U test
*Significant
Table 3 Variables included in the final model that
predicts leptospirosis complications
Clinical feature p Odds ratio 95% confidence interval
Oliguria .049* 4.140 1.003 to 17.261
Jaundice .033* 5.673 1.149 to 28.003
Arrhythmias .050* 5.774 1.001 to 34.692
*Significant
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ure was a major complication in our patients. Oliguria
has shown to predict acute renal failure but not BU, K,
and creatinine. It may be that serum biochemical mar-
kers lag behind the clinical presentation of acute renal
failure in leptospirosis but the exact mechanism is
unknown.
As oliguria, jaundice and arrhythmia point towards
involvement of three distinct organ systems, it is possi-
ble that all three clinical features herald multi organ
involvement in severe disease with different organs
involved in different severity.
Many outcome prediction scores have been developed
for the critically ill patients e.g. APACHE 11, but none of
them have been validated for leptospirosis. According to
our study, presence of the three clinical variables oliguria,
jaundice and arrhythmias predict acute renal failure and
myocarditis hence can be utilized to decide which patient
should receive intensive/high dependency care.
Limitations of the study
Present study was carried out within the limited
resources for diagnosis of leptospirosis as shown pre-
viously. Due to this lack of point of care diagnostic facil-
ities, there were several limitations to our study.
Although none of the laboratory confirmed cases died,
three patients suspected of having leptospirosis died
before serology could be performed, and were not
included in the study, which could have introduced a
selection bias in the sample. The cases included were
based on a single sample MAT titre, which is not the
standard test for confirmation. Further, it has been
shown that development of antibody might take more
than seven days in some patients. These could have
missed out some of the patients with leptospirosis. Pre-
vious studies have shown that complications of leptos-
pirosis depend on infecting serovars, which in this study
we were unable to study due to resource limitations.
Although all patients were studied as a single sample,
complications and predictors could be varied for differ-
ent serovars. Duration from the onset of the illness to
the admission was varied which could have had some
confounding effect on the investigations done on admis-
sion. This could be a reason why laboratory measures
were poor in predicting the complications. Due to the
lack of facilities we couldn’t confirm myocarditis histolo-
gically and it was done with clinical, electrocardiographi-
cal and echocardiographical evidence. But histological
confirmation would not change the management of a
leptospirosis patient with myocarditis.
Conclusions
This study shows that out of 17 variables, only oliguria,
jaundice and arrhythmia are strong predictors of
development of acute renal failure or myocarditis and
none of the laboratory variables could predict these
complications in patients with leptospirosis presented to
Teaching Hospital of Kandy, Sri Lanka.
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